A case of locally advanced sigmoid colon cancer curatively resected after neoadjuvant chemotherapy with FOLFIRI plus panitumumab

Kohei Horioka, Keizo Kaku, Sei Ichirou Jimi, Yoshihiro Oohata, Takafumi Kamei

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

A 72-year-old woman having abdominal pain and high fever was diagnosed with KRAS wild-type sigmoid colon cancer, invading the urinary bladder and uterus with a pelvic abscess. Considering the difficulty of curative resection, we first performed sigmoid colostomy and abscess drainage. Remarkable tumor regression was indicated by CT and colonoscopy after 1 course of FOLFIRI and 5 courses of FOLFIRI+panitumumab. Following an additional 2 courses of panitumumab, sigmoidectomy and partial cystectomy were performed. Six courses of FOLFIRI+panitumumab were administered postoperatively and no recurrence has been observed for 7 months. FOLFIRI+panitumumab may be an effective preoperative chemotherapy for patients with KRAS wild-type locally advanced colon cancer.

Original languageEnglish
Pages (from-to)397-399
Number of pages3
JournalJapanese Journal of Cancer and Chemotherapy
Volume40
Issue number3
Publication statusPublished - Mar 2013

Fingerprint

Sigmoid Neoplasms
Drug Therapy
Abscess
Colostomy
Cystectomy
Sigmoid Colon
Colonoscopy
Colonic Neoplasms
Abdominal Pain
Uterus
Drainage
Urinary Bladder
Fever
Recurrence
panitumumab
Neoplasms

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

A case of locally advanced sigmoid colon cancer curatively resected after neoadjuvant chemotherapy with FOLFIRI plus panitumumab. / Horioka, Kohei; Kaku, Keizo; Jimi, Sei Ichirou; Oohata, Yoshihiro; Kamei, Takafumi.

In: Japanese Journal of Cancer and Chemotherapy, Vol. 40, No. 3, 03.2013, p. 397-399.

Research output: Contribution to journalArticle

@article{9da39eb066da4c2b80d3799be4215176,
title = "A case of locally advanced sigmoid colon cancer curatively resected after neoadjuvant chemotherapy with FOLFIRI plus panitumumab",
abstract = "A 72-year-old woman having abdominal pain and high fever was diagnosed with KRAS wild-type sigmoid colon cancer, invading the urinary bladder and uterus with a pelvic abscess. Considering the difficulty of curative resection, we first performed sigmoid colostomy and abscess drainage. Remarkable tumor regression was indicated by CT and colonoscopy after 1 course of FOLFIRI and 5 courses of FOLFIRI+panitumumab. Following an additional 2 courses of panitumumab, sigmoidectomy and partial cystectomy were performed. Six courses of FOLFIRI+panitumumab were administered postoperatively and no recurrence has been observed for 7 months. FOLFIRI+panitumumab may be an effective preoperative chemotherapy for patients with KRAS wild-type locally advanced colon cancer.",
author = "Kohei Horioka and Keizo Kaku and Jimi, {Sei Ichirou} and Yoshihiro Oohata and Takafumi Kamei",
year = "2013",
month = "3",
language = "English",
volume = "40",
pages = "397--399",
journal = "Japanese Journal of Cancer and Chemotherapy",
issn = "0385-0684",
publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",
number = "3",

}

TY - JOUR

T1 - A case of locally advanced sigmoid colon cancer curatively resected after neoadjuvant chemotherapy with FOLFIRI plus panitumumab

AU - Horioka, Kohei

AU - Kaku, Keizo

AU - Jimi, Sei Ichirou

AU - Oohata, Yoshihiro

AU - Kamei, Takafumi

PY - 2013/3

Y1 - 2013/3

N2 - A 72-year-old woman having abdominal pain and high fever was diagnosed with KRAS wild-type sigmoid colon cancer, invading the urinary bladder and uterus with a pelvic abscess. Considering the difficulty of curative resection, we first performed sigmoid colostomy and abscess drainage. Remarkable tumor regression was indicated by CT and colonoscopy after 1 course of FOLFIRI and 5 courses of FOLFIRI+panitumumab. Following an additional 2 courses of panitumumab, sigmoidectomy and partial cystectomy were performed. Six courses of FOLFIRI+panitumumab were administered postoperatively and no recurrence has been observed for 7 months. FOLFIRI+panitumumab may be an effective preoperative chemotherapy for patients with KRAS wild-type locally advanced colon cancer.

AB - A 72-year-old woman having abdominal pain and high fever was diagnosed with KRAS wild-type sigmoid colon cancer, invading the urinary bladder and uterus with a pelvic abscess. Considering the difficulty of curative resection, we first performed sigmoid colostomy and abscess drainage. Remarkable tumor regression was indicated by CT and colonoscopy after 1 course of FOLFIRI and 5 courses of FOLFIRI+panitumumab. Following an additional 2 courses of panitumumab, sigmoidectomy and partial cystectomy were performed. Six courses of FOLFIRI+panitumumab were administered postoperatively and no recurrence has been observed for 7 months. FOLFIRI+panitumumab may be an effective preoperative chemotherapy for patients with KRAS wild-type locally advanced colon cancer.

UR - http://www.scopus.com/inward/record.url?scp=84878063190&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878063190&partnerID=8YFLogxK

M3 - Article

C2 - 23507607

AN - SCOPUS:84878063190

VL - 40

SP - 397

EP - 399

JO - Japanese Journal of Cancer and Chemotherapy

JF - Japanese Journal of Cancer and Chemotherapy

SN - 0385-0684

IS - 3

ER -